A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients
Clinical trial NCT04369846 · COMPLETED
Trial details
- NCT number
- NCT04369846
- Sponsor
- Xantho Biotechnology Co., LTD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-04
- Primary completion
- 2025-01-22
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.